Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03573752
Other study ID # 6796
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 26, 2018
Est. completion date October 14, 2021

Study information

Verified date August 2022
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Laparoscopic promontofixation is becoming increasingly common and is currently the standard surgical procedure for pelvic prolapse, with few complications including exposure and mesh infection. The research hypothesis is that laparoscopic promontofixation is a relatively painless procedure and can be performed on an outpatient basis without increasing the number of postoperative complications and impairing patients' quality of life. The objective of this study is to evaluate the number of rehospitalizations after management of promontofixation by laparoscopy on an outpatient basis. To evaluate the feasibility of a postoperative H8 exit after laparoscopic promontofixation. Each patient will complete a questionnaire on the experience of management, both in terms of pain management, anxiety and overall satisfaction.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 14, 2021
Est. primary completion date October 14, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Woman with promontofixation indication by laparoscopy for prolapse cure - Patient's desire for outpatient management - Age =18 years and <70 years - Absence of a major medical or surgical history that would prolong hospitalization (ASA 1 or 2, absence of Obstructive Sleep Apnea Syndrome) - Subject affiliated to a social security scheme - Subject having signed an informed consent - Availability of a caregiver, responsible and valid (for the first 48 hours after the potential early exit) at home - Geographical distance less than one hour from a suitable care facility - Access to a telephone or a means of transport if necessary - Patient compliance - Oral and written comprehension of pre- and post-operative instructions - Correct housing condition - Subject having been informed of the results of the prior medical examination Exclusion Criteria: - Laparoscopic contraindication - Comorbidity needs of medical supervision most of 24h - TVT-O procedure during the same surgery - Mental handicap affecting autonomy - Comprehension difficulties to understand the protocol - No social protection - Subject with curatorship or guardianship - Morbid obesity - Alcohol or drugs addiction - Excessive anxiety - Impossibility to give the subject enlightened information (subject in emergency situation...) - Pregnant woman (positive urinary pregnancy test for women of childbearing age)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
outpatient management for promontofixation by laparoscopy
postoperative H8 exit after laparoscopic promontofixation
questionnaire
Each patient will complete a questionnaire on the experience of management, both in terms of pain management, anxiety and overall satisfaction.

Locations

Country Name City State
France Service de gynécologie, Centre Médico Chirurgical Obstétrical, Hôpitaux Universitaires de Strasbourg Schiltigheim

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of rehospitalizations occurring between outpatient discharge and postoperative follow-up consultation Rate of rehospitalizations occurring between outpatient discharge and postoperative 35 to 70 Days after the intervention
Secondary Exit rate at postoperative H8 according to post-anesthesia discharge scoring system score according to Chung. This score considers six criteria: vital signs, ambulation, nausea/vomiting, pain, bleeding and voiding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a score of 9 or more are considered ready for discharge. Hour 8 after the intervention
Secondary Quality of life assessed by the Euroqol EQ-5D index (EuroQol five dimension scale) The EQ-5D questionnaire is made up for two components; health state description and evaluation. In description part, health status is measured in terms of five dimensions; mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The respondents self-rate their level of severity for each dimension using three-level (3L) scale; having no problems, having some or moderate problems, being unable to do/having extreme problems. The respondents are asked to choose the statement which best describes their health status of surveyed day.
In evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS). The patient is asked to mark health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to "the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine".
Day 0, 3, 7 and 30 after the intervention
Secondary Assess the satisfaction of the patients by answering a Patient Satisfaction Questionnaire Assess the satisfaction of the patients by answering a Patient Satisfaction Questionnaire. It includes a satisfaction scale ranging from 0 to 10 and 2 closed-response questions, with the possibility of adding a free comment. Day 30 after the intervention
Secondary Assess the postoperative anxiety by the State-Trait Anxiety Inventory (STAI) form Y-A. Assess the postoperative anxiety by the State-Trait Anxiety Inventory (STAI) form Y-A. This form has 20 items for assessing state anxiety. All items are rated on a 4-point scale. Higher scores indicate greater anxiety. Day 0, 1, 2, 3, 7 and 30 after the intervention
Secondary Assess postoperative pain by the Visual Analogue Scale (VAS) and the consumption of analgesics. Assess postoperative pain by the Visual Analogue Scale (VAS) and the consumption of analgesics. This scale consists of a straight line with the endpoints defining extreme limits such as "no pain at all" and "pain as bad as it could be". The patient is asked to mark his pain level on the line between the two endpoints. The distance between "no pain at all" and the mark then defines the subject's pain. 8 hours after surgery (Day 0)/ At 8 a.m. and 6 p.m. (Day 1, 2 and 3)/ At 8 a.m. (Day 4, 5, 6, 7 and 30)
Secondary Rates of postoperative complications Rates of postoperative complications 35 to 70 Days after the intervention
Secondary Number of emergency consultations before scheduled postoperative follow-up consultation Number of emergency consultations before scheduled postoperative follow-up consultation 35 to 70 Days after the intervention
Secondary Difference in actual costs and cost-effectiveness between conventional and outpatient care Collection of the PMSI (medical information system program) of the made act and the cost of the hospital stay in ambulatory for a laparoscopic promontofixation. 35 to 70 Days after the intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05420831 - Comparison of Vaginal and Laparoscopic Apical Fixation Techniques for Pelvic Organ Prolapse Treatment N/A
Active, not recruiting NCT05422209 - The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair. N/A
Completed NCT05493735 - Lidocaine for Pessary Check Pain Reduction Phase 3
Completed NCT06126328 - Materna Prep Study Phase II Phase 2
Recruiting NCT05542836 - EVeRLAST 2-Year Follow-Up
Recruiting NCT05918367 - Multicenter Ventral Mesh Rectopexy Registry Collaborative
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Recruiting NCT04807920 - BOTOX® at the Time of Prolapse Surgery for OAB Phase 4
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Recruiting NCT03146195 - The 3D Reconstruction Research of Pelvic Organ Prolapse Disease N/A
Recruiting NCT02919852 - Laparoscopic Retrovesical Colpopectinopexia N/A
Completed NCT02925585 - Vaginal Tactile Imaging for Pelvic Floor Prolapse
Not yet recruiting NCT02536001 - Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes N/A
Recruiting NCT02113969 - Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol N/A
Completed NCT02383199 - Polypropylene Mesh in Prolapse Surgery N/A
Terminated NCT01673360 - Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices N/A
Completed NCT01842464 - Sacro-Spinous Ligaments Anterior Apical Anchoring N/A
Withdrawn NCT01530191 - Factors Affecting Perioperative Outcomes N/A
Completed NCT01320631 - Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction N/A
Completed NCT00581412 - Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates N/A